Literature DB >> 1964842

Amphetamine behavioral sensitization and the excitatory amino acids.

R Karler1, I A Chaudhry, L D Calder, S A Turkanis.   

Abstract

The effects of 8 selective neuroeffector agonists and antagonists were measured in mice in order to identify specific functional changes associated with behavioral sensitization to amphetamine-induced stereotypy. The changes observed included a decreased convulsive threshold to N-methyl-DL-aspartic acid, an increased convulsive threshold to bicuculline, and an increased head-twitch response to 5-hydroxytryptophan. Of these effects, only the persistence of the two convulsive threshold changes correlated with the persistence of the behavioral sensitization. The induction of behavioral sensitization was blocked by haloperidol, dizocilpine or ketamine, but not affected by cyproheptadine or diazepam: therefore, the mechanism of the enhanced responsiveness involves not only a functional dopamine system, but also a functional N-methyl-D-aspartic acid component of the excitatory amino acid system. The block of behavioral sensitization also prevented the amphetamine-induced changes in the convulsive thresholds. Finally, neither ketamine nor dizocilpine affected the expression of the enhanced response in the behaviorally sensitized animals. The data indicate that the characteristics of amphetamine behavioral sensitization to stereotypy are similar to those of long-term potentiation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1964842     DOI: 10.1016/0006-8993(90)90341-8

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  15 in total

1.  Behavioral and neurochemical recovery from partial 6-hydroxydopamine lesions of the substantia nigra is blocked by daily treatment with D1/D5, but not D2, dopamine receptor antagonists.

Authors:  A Emmi; H Rajabi; J Stewart
Journal:  J Neurosci       Date:  1997-05-15       Impact factor: 6.167

2.  Evidence for dissociable mechanisms of amphetamine- and stress-induced behavioral sensitization: effects of MK-801 and haloperidol pretreatment.

Authors:  B K Tolliver; L B Ho; M S Reid; S P Berger
Journal:  Psychopharmacology (Berl)       Date:  1996-08       Impact factor: 4.530

3.  Dynamics of behavioral sensitization induced by the dopamine agonist quinpirole and a proposed central energy control mechanism.

Authors:  H Szechtman; H Talangbayan; G Canaran; H Dai; D Eilam
Journal:  Psychopharmacology (Berl)       Date:  1994-06       Impact factor: 4.530

4.  Development and expression of sensitization to cocaine's reinforcing properties: role of NMDA receptors.

Authors:  S Schenk; A Valadez; C McNamara; D T House; D Higley; M G Bankson; S Gibbs; B A Horger
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

5.  Development of both conditioning and sensitization of the behavioral activating effects of amphetamine is blocked by the non-competitive NMDA receptor antagonist, MK-801.

Authors:  J Stewart; J P Druhan
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

6.  Comparative behavioral sensitization to stereotypy by direct and indirect dopamine agonists in CF-1 mice.

Authors:  J B Bedingfield; L D Calder; R Karler
Journal:  Psychopharmacology (Berl)       Date:  1996-04       Impact factor: 4.530

7.  Cocaine behavioral sensitization and the excitatory amino acids.

Authors:  R Karler; L D Calder; J B Bedingfield
Journal:  Psychopharmacology (Berl)       Date:  1994-07       Impact factor: 4.530

8.  Behavioural and neurochemical adaptations to nicotine in rats: influence of NMDA antagonists.

Authors:  M Shoaib; M E Benwell; M T Akbar; I P Stolerman; D J Balfour
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

9.  Effects of dizocilpine [(+)-MK-801] on the expression of associative and non-associative sensitization to D-amphetamine.

Authors:  M Grönig; A Atalla; K Kuschinsky
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-12-12       Impact factor: 3.000

10.  Long-lasting induction of astrocytic basic fibroblast growth factor by repeated injections of amphetamine: blockade by concurrent treatment with a glutamate antagonist.

Authors:  C Flores; D Rodaros; J Stewart
Journal:  J Neurosci       Date:  1998-11-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.